0.00Open0.00Pre Close0 Volume0 Open Interest55.00Strike Price0.00Turnover215.56%IV-31.08%PremiumMay 9, 2025Expiry Date24.80Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9885Delta0.0022Gamma3.21Leverage Ratio-0.0584Theta0.0033Rho3.18Eff Leverage0.0019Vega
Merck & Co Stock Discussion
For the revenue consensus estimate, analysts anticipate revenue around $15.48 billion, which would be a slight decrease of about 1.9% year-over-year.
Wall Street expects Merck to report EPS of approximately $2.16. This would r...
Landmark Trial: Merck's New PAH Drug Shows Stunning 76% Reduction in Life-Threatening Events
No comment yet